logo

For the Inventor, By the Inventor

Bethesda, MD, United States of America

Mikulas Popovic

This inventor holds 17 USPTO granted patents, primarily in HIV Molecular Cloning. Top assignees: The United States of America as Represented by the Department of Health, Institut Pasteur, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1985-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mikulas Popovic. Retrieved from https://idiyas.com/inventor/mikulas-popovic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 8

Forward Citations = 370(Granted Patents)


Company Filing History:

goldMedal6 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
silverMedal5 out of 898 
 
Institut Pasteur
 patents
bronzeMedal4 out of 3,699 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
4. 3 out of 2,202 
 
The United States of America as Represented by the Secretary of
 patents
5. 4 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 1985-2016

Loading Chart...
Areas of Expertise:
Molecular Cloning
HIV-1
Antibody Detection
Genomic RNA
Viral Strains
Retroviruses
Isolation Methods
LAV Antigens
Serological Detection
Immunodeficiency Virus
Continuous Production
Monoclonal Antibodies
17 patents (USPTO):Explore Patents
1. 9309574 - Molecular cloning of HIV-1 from immortalized cell lines (2016-04-12),
2. 7232654 - DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1) (2007-06-19),
3. 7217508 - Cloned DNA sequence related to genomic RNA of human immunodeficiency virus (HIV-1) (2007-05-15),
4. 7205102 - Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated virus (LAV) and proteins encoded by said LAV genomic RNA (2007-04-17),
5. 6627395 - Methods for the propagation, isolation, identification, and preparation of human immunodeficiency virus type 1 (HIV-1) (2003-09-30),
6. 6600023 - Antibody directed against HIV-1 P25 antigen (2003-07-29),
7. 6428952 - Methods and kits employing LAV antigens for the detection of HIV-1-specific antibodies (2002-08-06),
8. 6395495 - Methods and kits for detecting antibodies against an HIV variant (2002-05-28),
9. 5869313 - Molecular clones of HIV-1 viral strains MN-ST1 and BA-L, and uses thereof (1999-02-09),
10. 5576000 - Molecular clones of HIV-1 viral strains MH-ST1 and BA-L, and uses thereof (1996-11-19),
11. 5420030 - Molecular clones of HIV-1 viral strains MN-ST1 and BA-L and uses thereof (1995-05-30),
12. 5254457 - Monoclonal antibodies and method for identifying different aids-related (1993-10-19),
13. 5135864 - Human Immunodeficiency Virus (HIV) associated with Acquired Immunual (1992-08-04),
14. 4708818 - Human immunodeficiency viruses associated with Acquired Immune (1987-11-24),
15. 4652599 - Method of continuous production of retroviruses (HTLV-III) from patients (1987-03-24),

Title: Mikulas Popovic: Innovator in HIV Research

Introduction

Mikulas Popovic, based in Bethesda, MD, is a distinguished inventor renowned for his significant contributions to HIV research. With a remarkable portfolio of 17 patents, his work has led to advancements in diagnostic and therapeutic measures for AIDS, showcasing a commitment to improving public health.

Latest Patents

Among his latest inventions is the molecular cloning of HIV-1 from immortalized cell lines. This groundbreaking patent discloses the molecular cloning of HTLV-III, the virus responsible for adult leukemia and acquired immune deficiency syndrome (AIDS). Clone BH10 contains a 9.0 Kb viral insert representing the entire HTLV-III genome, while clones BH8 and BH5 feature viral inserts of 5.5 Kb and 3.5 Kb, respectively. These clones serve as vital resources for the development of diagnostic tools and treatment strategies for AIDS, as well as probes for detecting the virus.

Another notable patent involves the DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1). This invention focuses on detecting the presence of DNA, RNA, or antibodies associated with the lymphadenopathy retrovirus, which is linked to acquired immune deficiency syndrome. The patent includes DNA fragments, vectors, and proteins essential for detecting and understanding this devastating virus.

Career Highlights

Throughout his career, Mikulas Popovic has made significant strides in the field of virology. His inventive work has received recognition and has had a profound impact on AIDS research and treatment. His patents reflect a deep understanding of viral behaviors and the complexities of retroviruses.

Collaborations

Mikulas has had the privilege of collaborating with renowned scientists in the field, including Robert C. Gallo and Luc Montagnier. These collaborations have fostered an exchange of ideas and pushed the boundaries of research focused on HIV and AIDS.

Conclusion

Mikulas Popovic’s innovative spirit and dedication to HIV research have resulted in substantial advancements in understanding and combating AIDS. His contributions through multiple patents not only highlight his role as an inventor but also impact countless lives around the globe. As research continues to evolve, the significance of his work will undeniably remain influential in the ongoing battle against HIV/AIDS.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…